Bespak, established in 1959, is a leading global Contract Development and Manufacturing Organisation (CDMO) with a core focus on inhaled and nasal drug delivery. Positioned strategically within the intersection of health care and manufacturing, Bespak has carved out a significant niche as a supplier of drug delivery devices and componentry to the pharmaceutical industry.
Headquartered in Holmes Chapel, UK, Bespak's comprehensive service suite spans the entire product lifecycle. The company is distinguished by its expertise in the development and mass production of complex dry powder inhaler (DPI) devices and pressurised Metered Dose Inhalers (pMDIs). It holds a substantial market share in pMDI dosing valves, evidencing its technical and commercial prowess.
Despite its substantial legacy, Bespak has not reported any recent external investments, hinting at a possibly stable or internally-driven growth strategy. This could represent a unique opportunity for potential investors looking to penetrate the niche market of drug-device combination products.